tradingkey.logo
tradingkey.logo
Suchen

SNWV

SNWV
Zur Watchlist hinzufügen
16.850USD
-0.220-1.29%
Handelsschluss 05/15, 16:00ETKurse um 15 Minuten verzögert
144.89MMarktkapitalisierung
8.99KGV TTM

mehr Informationen über SANUWAVE Health Inc Unternehmen

Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.

SNWV Informationen

BörsenkürzelSNWV
Name des UnternehmensSANUWAVE Health Inc
IPO-datumNov 07, 2008
CEOFrank (Morgan C)
Anzahl der mitarbeiter46
WertpapierartOrdinary Share
GeschäftsjahresendeNov 07
Addresse9600 W. 6Th Sstreet
StadtEDEN PRAIRIE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl55344
Telefon19526561029
Websitehttps://sanuwave.com/
BörsenkürzelSNWV
IPO-datumNov 07, 2008
CEOFrank (Morgan C)

Führungskräfte von SNWV

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ian Miller
Mr. Ian Miller
Lead Independent Director
Lead Independent Director
48.43K
--
Mr. Peter Stegagno
Mr. Peter Stegagno
Chief Regulatory Officer
Chief Regulatory Officer
2.03K
--
Dr. Iulian Cioanta, Ph.D.
Dr. Iulian Cioanta, Ph.D.
Chief Science and Technology Officer
Chief Science and Technology Officer
41.00
--
Mr. Daniel Coyle
Mr. Daniel Coyle
Chief Operating Officer
Chief Operating Officer
37.00
--
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
Independent Director
Independent Director
--
-100.00%
Mr. Jim (Jim) Tyler
Mr. Jim (Jim) Tyler
Independent Director
Independent Director
--
--
Mr. Morgan C. Frank
Mr. Morgan C. Frank
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Peter Sorensen
Mr. Peter Sorensen
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Timothy Wern
Mr. Timothy Wern
Executive Vice President - Sales, U.S. Wound Business
Executive Vice President - Sales, U.S. Wound Business
--
--
Mr. Gregory (Greg) Bazar
Mr. Gregory (Greg) Bazar
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ian Miller
Mr. Ian Miller
Lead Independent Director
Lead Independent Director
48.43K
--
Mr. Peter Stegagno
Mr. Peter Stegagno
Chief Regulatory Officer
Chief Regulatory Officer
2.03K
--
Dr. Iulian Cioanta, Ph.D.
Dr. Iulian Cioanta, Ph.D.
Chief Science and Technology Officer
Chief Science and Technology Officer
41.00
--
Mr. Daniel Coyle
Mr. Daniel Coyle
Chief Operating Officer
Chief Operating Officer
37.00
--
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
Independent Director
Independent Director
--
-100.00%
Mr. Jim (Jim) Tyler
Mr. Jim (Jim) Tyler
Independent Director
Independent Director
--
--

Umsatzaufteilung

FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q2
FY2021
FY2020
FY2019
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States (Country)
44.05M
0.00%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Sun, May 10
Aktualisiert: Sun, May 10
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Manchester Management Company, L.L.C.
10.79%
Opaleye Management Inc.
9.98%
AWM Investment Company, Inc.
5.29%
BlackRock Institutional Trust Company, N.A.
5.26%
Vanguard Capital Management, LLC
4.06%
Andere
64.62%
Aktionäre
Aktionäre
Anteil
Manchester Management Company, L.L.C.
10.79%
Opaleye Management Inc.
9.98%
AWM Investment Company, Inc.
5.29%
BlackRock Institutional Trust Company, N.A.
5.26%
Vanguard Capital Management, LLC
4.06%
Andere
64.62%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
27.45%
Investment Advisor
13.30%
Investment Advisor/Hedge Fund
12.76%
Bank and Trust
2.13%
Individual Investor
1.33%
Research Firm
0.94%
Pension Fund
0.13%
Insurance Company
0.03%
Andere
41.92%

Institutionelle Beteiligung

Aktualisiert: Wed, Apr 1
Aktualisiert: Wed, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
125
5.44M
63.34%
+562.83K
2025Q4
109
4.37M
50.95%
-566.14K
2025Q3
88
4.71M
54.97%
+846.01K
2025Q2
48
4.81M
56.23%
+1.02M
2025Q1
33
4.13M
48.25%
+281.09K
2024Q4
13
3.70M
91.09%
+2.41M
2024Q3
12
1.26M
39.85%
+274.18K
2024Q2
13
983.35K
31.89%
-13.84K
2024Q1
14
960.39K
31.58%
-14.91K
2023Q4
15
1.16M
53.72%
+592.61K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Manchester Management Company, L.L.C.
927.98K
10.8%
-162.81K
-14.93%
Dec 12, 2025
Opaleye Management Inc.
981.27K
11.42%
+1.27K
+0.13%
Dec 31, 2025
AWM Investment Company, Inc.
454.55K
5.29%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
452.46K
5.26%
+12.61K
+2.87%
Dec 31, 2025
Solas Capital Management, LLC
293.53K
3.42%
+92.22K
+45.81%
Dec 31, 2025
Praetorian Capital Management, L.L.C.
265.00K
3.08%
+247.75K
+1436.23%
Dec 31, 2025
Stifel, Nicolaus & Company, Incorporated
177.30K
2.06%
+177.30K
--
Dec 31, 2025
Geode Capital Management, L.L.C.
167.26K
1.95%
+5.38K
+3.32%
Dec 31, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Micro-Cap ETF
0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
Franklin US Small Cap Multifactor Index ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Micro-Cap ETF
Anteil0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.03%
iShares Russell 2000 ETF
Anteil0.01%
Proshares Ultra Russell 2000
Anteil0.01%
ProShares UltraPro Russell2000
Anteil0.01%
Franklin US Small Cap Multifactor Index ETF
Anteil0.01%
iShares Russell 2000 Growth ETF
Anteil0.01%
Global X Russell 2000 ETF
Anteil0.01%
ProShares Hedge Replication ETF
Anteil0.01%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI